Clinical Trial 17195

Houston, TX 77008

Study Summary:

A phase 3 randomized. double-blind clinical trial to study the efficacy and safety of a fixed dose combination drug for the treatment of patients with type 2 diabetes and inadequate glycemic control on metformin mono therapy.

Qualified Participants Must:

• Be between 18 and 79 years of age
• Be taking at least 1500mg of Metformin daily
• Not be taking any lipid-lowering medications (high cholesterol meds)
• Not have recently started a weight loss program or had bariatric surgery within last 12 months

Qualified Participants May Receive:

All study-related labs, doctor's exams, study medications free of charge and compensation may be available to qualified subjects.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.